Brian A Markison is Chief Executive Officer of RVL Pharmaceuticals plc. Currently has a direct ownership of 2.98 Million shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on Aug 08, 2022, when has been sold 850,000 shares (Ordinary Shares) at a price of $1.55 per share, resulting in proceeds of $1,317,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.98M
0% 3M change
0% 12M change
Total Value Held $0

BRIAN A MARKISON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2022
BUY
Open market or private purchase
$1,317,500 $1.55 p/Share
850,000 Added 22.22%
2,976,020 Ordinary Shares

Also insider at

LNTH
Lantheus Holdings, Inc. Healthcare
BAM

Brian A Markison

Chief Executive Officer
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP